CAMBRIDGE, England, Nov. 2, 2023 /PRNewswire/ — Mission Therapeutics (“Mission”), a clinical-stage biotech company developing first-in-class therapeutics targeting mitophagy, today announces that it will present an oral abstract on its experimental drug candidate MTX652 at the American…
Join this webinar to gain insights into the challenges and innovations in mRNA vaccines in clinical trials.
Join experts from Aragen Life Sciences, Dr. Narendra Deshmukh, Executive Director; and Dr. Kedar Purnapatre, Director, Bioanalytical & Bioassay, for the live webinar on Wednesday, November 15, 2023, at 11am EST (4pm GMT/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
NEW YORK, Oct. 30, 2023 /PRNewswire/ — The blood bank refrigerators market size in US is expected to grow by USD 133.85 million from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 6.28% during the forecast period, according to Technavio Research. The…
¡ÚNETE AL RETO! 12 días, 10 horas, 1 libro. CIUDAD DE MÉXICO, 30 de octubre de 2023 /PRNewswire/ — El próximo lunes 6 de noviembre se realizará el lanzamiento del audiolibro “Medicina Funcional”, podrás escuchar, analizar y desmenuzar la obra junto con su coautor, el Dr. Alexander O…
NORWALK, Conn., Oct. 30, 2023 /PRNewswire/ — LifeSpan Vision Ventures, an investment firm dedicated to longevity biotech, today announced an investment in NaNotics LLC. This preclinical-stage biopharmaceutical company is developing NaNots™, novel subtractive nanoparticles that treat…
FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care. The statewide practice is at the forefront of innovative clinical research, enabling the most advanced treatments and cutting-edge technologies for all forms of cancers and blood disorders.
At around 100 locations throughout Florida, a team of more than 250 physicians, 220 advanced practitioners, and nearly 4,000 team members shares a commitment to ensuring that patients have access to world-class cancer care, close to home, with the support they need at every step of their cancer journey.
“We applaud FCS’ commitment to both patients and the advanced practitioners who care for them by joining APSHO as an Institutional Member,” commented Wendy Vogel, FNP, AOCNP®, FAPO, APSHO’s Executive Director. “APSHO and FCS will be working together to provide critical clinical information and professional education to their advanced practitioners. We know that the interdisciplinary team approach to cancer care is the best hope for improved patient outcomes.”
“We are proud to partner with APSHO, and in doing so, we are bringing some of the most advanced tools and resources to our advanced practitioners, who are integral members of the oncology care team,” said FCS Vice President of Nursing & Research, Colleen Lewis, MSN, ANP-BC, AOCNP®.
Institutional membership with APSHO provides institutions significant discounts on membership and clinical education, a cost savings that is essential at a time when educational budgets are shrinking and the science of oncology is expanding. The society offers advanced practitioners a rich network of oncology professionals to collaborate with. APSHO’s mentoring program gives professionals the opportunity to share expertise and best practices with colleagues across the country. The official journal of APSHO, the Journal of the Advanced Practitioner in Oncology, is a peer-reviewed, indexed publication that provides information on clinically relevant, evidence-based practice.
Learn more about APSHO and institutional membership at APSHO.org.
About APSHO
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for advanced practitioners: nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.
Dr. Funari’s impressive 20-year career has centered on integrating genomic technologies into precision medicine, particularly concerning hematologic and solid tumors. He is licensed as a Clinical Genetic Molecular Biologist Scientist (CGMBS) by the California Department of Health Care Services.
Robert Embree, Chief Executive Officer of EmeritusDX, expressed the company’s excitement: “EmeritusDX is thrilled to have such a well-respected genomics authority like Dr. Funari leading our research and innovation teams. Dr. Funari will be a vital member of the executive team, leveraging years of research expertise, clinical genomics experience, a strong network, and a passion for innovation in precision medicine.”
Upon accepting the role, Dr. Funari commented, “I am thrilled and honored to join the EmeritusDX team and be a part of an organization focused on providing first-in-class patient care. We will work diligently to offer a complete and robust menu for the entire cancer care continuum. I am extremely excited to deploy cutting-edge technology to impact the patients with cancer that EmeritusDX serves.”
About EmeritusDX
EmeritusDX is a cancer diagnostic and information company. Our expertise is in delivering actionable clinical information. Within our world-class laboratory, we perform testing that guides the diagnosis and treatment of cancer patients. Our partners include hospital and private pathology laboratories, biotechnology companies, academic institutions, contract research and pharmaceutical development organizations, and more. We understand the dependency on our accurate and timely results and our commitment to excellence in this regard is unwavering.
If you would like more information about this topic, please call 800-959-2846 or email [email protected]
Dr. Dorothee Bartels Brings Extensive Experience in Pharmacoepidemiology, Big Data Analytics and Public Health Michael Reitermann has Broad Background in Driving Technological Change and Innovation BETHLEHEM, Pa., Oct. 27, 2023 /PRNewswire/ — B. Braun of America Inc., a leader in smart…
“We were able to secure these designations after only five years as a graduate medical education (GME) program, solidifying our standing as a major academic medical center,” said Dr. Saima Chaudhry, Memorial Healthcare System‘s chief academic officer. “It also makes our program more attractive to residents, fellows, and teaching faculty as we maintain our commitment to train South Florida’s next generation of physicians and specialists.”
Memorial’s GME program, which uses its hospitals for on-the-job, physician training that supplements classroom instruction, includes 15 accredited programs (11 residencies and four fellowships). Many of these areas of study are ones the State of Florida has determined will likely have a shortage of specialists in the years to come.
Statutory teaching hospital designation also potentially qualifies academic centers for additional state funding for programs.
South Florida-based Memorial Healthcare System (http://www.mhs.net) is a national leader in quality care and patient, physician, and employee satisfaction. Its commitment to deeper caring and smarter health prioritizes a person-centered approach that has delivered safe, positive outcomes for 70 years.
Featuring multi-disciplinary collaboration, research, innovation, and transparency within its many facilities, Memorial is focused on removing barriers, increasing access, and providing equitable care throughout the region. It employs a staff of more than 16,000 and operates six hospitals, numerous primary, urgent, and 24/7 care facilities, medical office buildings, a health specialty center, and nursing home.
To learn more, visit mhs.net and connect on Facebook, X (formerly Twitter), Instagram, YouTube, and LinkedIn.
The DigiM™ Digital Maturity Momentum Awards are grounded in the DigiM™ Digital Maturity Framework, an invaluable tool for assessing and benchmarking digital maturity and progress within the realm of digital transformation. The awards ceremony is a recognition of excellence, a benchmarking exercise, and a platform for sharing best practices that can inspire and guide peers in the industry.
Why the DigiM™ Digital Maturity Momentum Awards Matter:
Recognition of Excellence: DigiM™ Award recipients are celebrated for their exceptional leadership in digital transformation, reflecting dedication and accomplishments in the field.
Benchmarking and Self-Reflection: The awards encourage organizations to assess their digital maturity, offering insights into strengths and areas for improvement, and fostering ongoing growth and development.
Sharing Best Practices: Participants have the opportunity to share their best practices and insights with a global audience, serving as valuable resources for others on their digital journey.
Inspiration for Others: Achievements in digital transformation can inspire and motivate others to strive for excellence, making the DigiM™ Awards a platform for sharing success stories that guide peers in the industry.
Award Categories:
Submissions for the DigiM™ Digital Maturity Momentum Awards will be evaluated in the following categories:
Digital Engagement Maturity: Recognizing organizations that have excelled in engaging their audiences effectively through digital channels.
Technology Engagement Maturity: Celebrating innovation and excellence in the implementation of digital technologies.
Overall Leadership in Digital Transformation Strategy and Execution: Honoring individuals, teams, or organizations that have demonstrated exceptional leadership and execution of digital transformation strategies.
“We are honored to be named an overall leader in the Damo Digital Maturity Awards program. The award is a recognition of the significant achievements and positive outcomes that we have made in digitally enabling our consumer, clinical, and employee experiences. Digital maturity is not the job of only one team in an organization. It’s a cultural shift made possible by the work of many hands – not all of them tech folks – across the care continuum. And as is true within our health systems, so too is this way of digital transformation for the American healthcare landscape: growth made possible by an ecosystem of providers and partner organizations across the country who motivate and inspire one another’s evolution,” says Emily Kagan Trenchard, Senior Vice President, Chief Consumer Digital Solutions, Northwell Health.
How to Submit Your Assessment:
To participate in the DigiM™ Awards, follow these steps:
Complete the assessment questionnaire (20–30 minutes).
Ensure all required information is accurate and up to date.
Submit your assessment by the deadline, November 08, 2023.
The DigiM™ Awards are an online event, with winners and honorees announced in January 2024. Every participant will receive a copy of their assessment, along with an opportunity to discuss their report with our experts. Damo Consulting looks forward to celebrating achievements and connecting with a community of digital transformation enthusiasts. We encourage all participants to share this opportunity with their networks, colleagues, and peers who have made notable contributions to the digital transformation landscape.
About the DigiM™ Awards
The DigiM™ Awards is an annual awards event that celebrates excellence in digital innovation. It recognizes and honors individuals, organizations, and projects that have made significant contributions to the digital world. For more information, please visit www.damoconsulting.net.
For inquiries or further information, please contact us at [email protected].